Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors

Baseline tumour measurements predict survival in advanced non-small cell lung cancer

(2013) D E Gerber et al.   BRITISH JOURNAL OF CANCER

Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance

(2013) Y Li et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Second-Line Therapy for Advanced NSCLC

(2013) J. M. Weiss et al.   ONCOLOGIST

Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

(2013) Jae Cheol Lee et al.   Cancer Research and Treatment

What is the role of maintenance therapy in the treatment of non-small cell lung cancer?

(2010) Yixing Jiang et al.   Therapeutic Advances in Medical Oncology

Cancer and the Environment: The American Cancer Society Prevention Priorities

(2009) G. A. Colditz   CA-A CANCER JOURNAL FOR CLINICIANS

Differences in Paclitaxel and Docetaxel Interactions with Tubulin Detected by Mutagenesis of Yeast Tubulin

(2008) Robert D. Winefield et al.   ChemMedChem

Docetaxel in the treatment of advanced non-small-cell lung cancer

(2008) Emmanouel Saloustros et al.   Expert Review of Anticancer Therapy